| 000 | 01737 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250513162504.0 | ||
| 264 | 0 | _c19990324 | |
| 008 | 199903s 0 0 eng d | ||
| 022 | _a0014-2999 | ||
| 024 | 7 |
_a10.1016/s0014-2999(98)00827-9 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKawaguchi, K | |
| 245 | 0 | 0 |
_aParallel dose-response studies of the voltage-dependent Na+ channel antagonist BW619C89, and the voltage-dependent Ca2+ channel antagonist nimodipine, in rat transient focal cerebral ischaemia. _h[electronic resource] |
| 260 |
_bEuropean journal of pharmacology _cJan 1999 |
||
| 300 |
_a99-105 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBlood Glucose _xdrug effects |
| 650 | 0 | 4 |
_aBlood Pressure _xdrug effects |
| 650 | 0 | 4 |
_aBody Temperature _xdrug effects |
| 650 | 0 | 4 |
_aBrain _xdrug effects |
| 650 | 0 | 4 |
_aCalcium Channel Blockers _xpharmacology |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aElectric Stimulation |
| 650 | 0 | 4 | _aHydrogen-Ion Concentration |
| 650 | 0 | 4 |
_aIschemic Attack, Transient _xphysiopathology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aNeuroprotective Agents _xpharmacology |
| 650 | 0 | 4 |
_aNimodipine _xpharmacology |
| 650 | 0 | 4 |
_aPiperazines _xpharmacology |
| 650 | 0 | 4 |
_aPyrimidines _xpharmacology |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 |
_aReperfusion Injury _xdrug therapy |
| 650 | 0 | 4 | _aSodium Channel Blockers |
| 700 | 1 | _aHenshall, D C | |
| 700 | 1 | _aSimon, R P | |
| 773 | 0 |
_tEuropean journal of pharmacology _gvol. 364 _gno. 2-3 _gp. 99-105 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0014-2999(98)00827-9 _zAvailable from publisher's website |
| 999 |
_c9894320 _d9894320 |
||